Perseverance, passion, and partnership are three words to describe the work of Lawrence Pfeffer and Duane Miller, researchers from the University of Tennessee Health Science Center, who have spent the last decade and a half studying treatment options for glioblastoma, an aggressive, lethal form of brain cancer. We had gotten close to being funded, but (read more)
UT Graduate School of Medicine
Long-term vision and partnership: UTRF startup to develop next-generation RNA medicines using a novel drug delivery system
Around a decade ago, a researcher at the University of Tennessee Graduate School of Medicine (UTSGM) and a graduate student in her lab began to imagine creating a company based on a technology they were developing. In 2022, their initial dream became a reality. They launched Orion Therapeutics, a biotechnology startup company developing next-generation RNA (read more)
UTRF Inventor Spotlight: Dr. Jonathan Wall
A “team effort” for discovering how to diagnose and treat amyloidosis, a rare protein-folding disorder. Amyloidosis is a rare disorder that occurs when an abnormal amyloid protein deposits in organs and tissues, interfering with their ability to function normally. There are approximately 30 different types of amyloidosis, and the disease can either be systemic or (read more)